Dianthus Therapeutics, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| DNTH | ABCL | VERA | 688382.SS | ROIV | VIR | |
|---|---|---|---|---|---|---|
| Market cap | 4.80B | 3.98B | 2.30B | 8.38B | 27.61B | 1.99B |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | -18.6 | -16.1 | -7.5 | -43.8 | -27.5 | -4.8 |
| Price/book | 7.5 | 4.2 | 5.6 | 6.6 | 6.5 | 2.1 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | +135.55% | +171.08% | +27.43% | −48.70% | +85.85% | +129.88% |
| Today | +3.76% | +0.82% | +4.10% | +4.33% | +6.08% | +4.90% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All DNTH news ›Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
The Manila Times The inducement grants consist of non-qualified stock options to purchase an aggregate of 26,000 shares of the Company's common stock with a 10-year term and an exercise price of $82.25 per share.
Dianthus Therapeutics (NASDAQ:DNTH) Stock Rating Raised to Strong-Buy at Roth Capital
Posted by Tristan Rich on Oct 28th, 2026 Dianthus Therapeutics (NASDAQ:DNTH – Get Free Report) was upgraded by stock analysts at Roth Capital to a “strong-buy” rating in a research report issued to clients and investors on Monday, Zacks…
Cleveland-based Diasome Pharmaceuticals announces $9.5 million first close on Series C financing round
The company is gearing up for a trial that will compare the effect its technology to standard care of insulin therapy in patients with type 1 diabetes. Cleveland-based Diasome Pharmaceuticals announces $9.5 million first close on Series C…
Dianthus Therapeutics Recognized Among Fortune’s 2026 Best Workplaces In BioPharma
The Manila Times Dianthus Therapeutics Recognized Among Fortune’s 2026 Best Workplaces In BioPharma NEW YORK and WALTHAM, Mass., Oct. 13, 2026 (GLOBE NEWSWIRE) -- Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinica
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- manilatimes.net2
- crainscleveland.com1
- stocktitan.net1
- themarketsdaily.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 5 articles, not a forecast.